LSL Pharma Group Inc
LSL.V - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$37.39M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $37.39 Million |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $- |
| Beta | -0.37 |
| Outstanding Shares | - |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Next Earnings Call
Expected Date
November 18, 2026
EPS Estimate
$-0.02
Consensus analyst estimateRevenue Estimate
$13.35 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About LSL Pharma Group Inc
252 employees
CEO: François Roberge
LSL Pharma Group, Inc. operates as a pharmaceutical company. It specializes in the development, manufacture and distribution of natural health products and dietary supplements in solid dosage forms as well as sterile ophthalmic pharmaceu...